The Research Progress in the Diagnosis and Treatment of Primary Intestinal Diffuse Large B-cell Lymphoma——Review
10.19746/j.cnki.issn1009-2137.2024.03.047
- VernacularTitle:原发性肠道弥漫大B细胞淋巴瘤的诊治研究进展
- Author:
Xiao-Jun CHEN
1
;
Su-Xia LIN
;
Yan-Quan LIU
Author Information
1. 莆田学院附属医院血液风湿科,福建莆田 351100
- Keywords:
diffuse large B-cell lymphoma;
intestinal tumors;
differential diagnosis;
prognosis
- From:
Journal of Experimental Hematology
2024;32(3):957-961
- CountryChina
- Language:Chinese
-
Abstract:
Primary intestinal diffuse large B-cell lymphoma(PI-DLBCL)is clinically rare,but in recent years,with the gradual maturity of pathology and molecular biology technology,its incidence rate and diagnosis rate have also increased.Due to the lack of specificity of the clinical symptoms of PI-DLBCL,it is easy to misdiagnose and miss the diagnosis,and there is no consensus on the best treatment of PI-DLBCL in clinical practice.Therefore,by retrieving the latest literature at home and abroad,this review systematically discusses the pathogenesis,clinical manifestations,diagnostic criteria,treatment and prognosis of PI-DLBCL,in order to improve the understanding of rare PI-DLBCL in hematology and oncology,and provide reference for basic research and clinical diagnosis and treatment of PI-DLBCL.
